PINTAIL LTD - Ireland 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Networking Rank (Reputation):900-1000
Partner Constancy:700-800
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):900-1000
2012
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:300-400
Total Number of Projects:66
Total Project Funding:500-600
Networking Rank (Reputation):800-900
Networking Rank (Reputation):800-900
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 33
As coordinator: 1
As participant: 32
Sole participant: 0
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 5.978.716 400.000 1
2021 0 12.705.650 405.763 2
2020 2.238.700 18.156.318 708.369 1 3
2019 0 10.812.123 508.750 3
2018 0 11.930.312 483.469 2
2016 0 5.995.761 250.000 1
2015 0 21.853.335 805.875 4
2014 0 14.314.894 637.240 3
2013 0 17.955.432 523.815 3
2012 0 26.265.620 2.088.366 6
2011 0 11.359.939 462.336 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
NATIONAL UNIVERSITY OF IRELAND GALWAY11
ROYAL COLLEGE OF SURGEONS IN IRELAND6
STICHTING KATHOLIEKE UNIVERSITEIT6
ORBSEN THERAPEUTICS LIMITED5
KATHOLIEKE UNIVERSITEIT LEUVEN4
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
ISTITUTO GIANNINA GASLINI3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
THE QUEEN'S UNIVERSITY OF BELFAST3
UNIVERSITA DEGLI STUDI DI GENOVA3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITY COLLEGE DUBLIN3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
VTT TECHNICAL RESEARCH CENTRE OF FINLAND3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BELFAST HEALTH AND SOCIAL CARE TRUST2
CARL ZEISS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DANISH CANCER SOCIETY2
DUBLIN CITY UNIVERSITY2
EPIGENOMICS2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
GENEXPLAIN2
INSTITUT DE RECHERCHE CONTRE LES CANCERS DE L'APPAREIL DIGESTIF2
ITHERA MEDICAL2
NHS BLOOD AND TRANSPLANT2
ONCOMARK LIMITED2
OPTIMATA2
PANCARE2
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
STENO DIABETES CENTER2
STICHTING VUVUMC2
TERVEYDEN JA HYVINVOINNIN LAITOS2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN2
THE UNIVERSITY OF EDINBURGH2
UNIVERSIDADE DE LISBOA2
UNIVERSITAET ZU LUEBECK2
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ2
UNIVERSITE PARIS DESCARTES2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK2
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN2
UNIVERSITY OF AARHUS2
UNIVERSITY OF CRETE2
UNIVERSITY OF ULSTER2
AALTO KORKEAKOULUSAATIO SR1
AARHUS UNIVERSITETSHOSPITAL1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACONDICIONAMIENTO TARRASENSE ASSOCIACION1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AGILENT TECHNOLOGIES ISRAEL1
AN GARDA SIOCHANA1
ARCTUR RACUNALNISKI INZENIRING DOO1
ARIES1
ASSOCIAZIONE DELLA CROCE ROSSA ITALIANA1
ASTON UNIVERSITY1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AXIVITY LIMITED1
AZIENDA LIGURE SANITARIA DELLA REGIONE LIGURIA1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BAYERISCHE AKADEMIE DER WISSENSCHAFTEN1
BIOINVISION INC1
BIORIGEN1
BIOSTOR IRELAND LIMITED1
BOYNE RESEARCH INSTITUTE LIMITED1
BRISTOLMYERS SQUIBB COMPANY1
BUNDESMINISTERIUM DER VERTEIDIGUNG1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST1
CANCER TRIALS IRELAND CLG1
CARR COMMUNICATIONS LIMITED1
CELL THERAPY CATAPULT LIMITED1
CENTRE FOR IRISH AND EUROPEAN SECURITY LIMITED1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER1
CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
CHILDHOOD CANCER INTERNATIONAL1
CID1
CLARISOFT TECHNOLOGIES ROM1
COMMETRIC EOOD1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
CONSORZIO INTERUNIVERSITARIO PER LA GESTIONE DEL CENTRO DI CALCOLO ELETTRONICO DELL'ITALIA NORD ORIENTALE1
CROSPON LIMITED1
CSCTIETEEN TIETOTEKNIIKAN KESKUS OY1
DANMARKS TEKNISKE UNIVERSITET1
DATAPIANO1
DET NATIONALE FORSKNINGSCENTER FOR ARBEJDSMILJO1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EINDHOVEN UNIVERSITY OF TECHNOLOGY1

Constancy:

Total number of partners: 354
Partner loyalty:
Frequent Partner: (> 2 projects): 71
Rare Partner: 283
Frequent / Rare Partner Ratio: 0.25

Project overview:

Start dateProjectacronymrolefundingpartners
2022-05-01VALIDATING AI IN CLASSIFYING CANCER IN REAL-TIME SURGERY CLASSICAparticipant5.978.71611
2021-03-01PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors PanCareSurPassparticipant4.000.00019
2021-02-01Pandemic Preparedness and Response PANDEM-2participant8.705.65023
2020-11-01Controlling viral aerosols in COVID-19 and beyond PORSAVcoordinator2.238.7005
2020-06-01Heterogenous Photo(electro)catalysis in Flow using Concentrated Light: modular integrated designs for the production of useful chemicals FlowPhotoChemparticipant6.993.31515
2020-01-01Mental Health Promotion and Intervention in Occupational Settings: MENTUPP MENTUPPparticipant3.710.23320
2020-01-01Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis AutoCRATparticipant7.452.7709
2019-02-01PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease PD-MitoQUANTparticipant4.497.93514
2019-01-01PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers PanCareFollowUpparticipant3.999.87314
2019-01-01Enhancing Ultrasound and PHOtoacoustics for Recognition of Intestinal Abnormalities EUPHORIAparticipant2.314.3155
2018-01-01NanoSTARS imaging for STEM cell therapy for arthritic joints STARSTEMparticipant5.933.9529
2018-01-01Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions COLOSSUSparticipant5.996.36014
2016-01-01Development of closed, scalable and AUTOmated robotic systems for therapeutic STEM cell manufacturing: aseptic systems from “Donor-to-Patient” AUTOSTEMparticipant5.995.76110
2015-11-01The Novel Materials Discovery Laboratory NoMaDparticipant4.910.62411
2015-05-01Novel Stromal Cell Therapy for Diabetic Kidney Disease NEPHSTROMparticipant5.994.37411
2015-03-01Evidence-based ICT tools for weight loss maintenance NoHoWparticipant4.949.33714
2015-01-01Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis ADIPOA2participant5.999.00018
2014-04-01Adverse Immune Signatures and their Prevention in Corneal Transplantation VISICORTparticipant5.989.49112
2014-04-01Security System for language and image analysis SLANDAILparticipant2.942.44512
2014-02-01MEsenchymal stem cells to Reduce Liver INflammation MERLINparticipant5.382.9588
2013-12-01A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients MERCURICparticipant5.999.99513
2013-11-01Social innovation to improve physical activity and sedentary behaviour through elite European football clubs: European Fans in Training EUROFITparticipant5.957.15812
2013-11-01"PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood" PANCARELIFEparticipant5.998.27916
2012-11-01Apoptosis Modelling for Treatment Decisions in Colorectal Cancer APO-DECIDEparticipant2.999.4827
2012-11-01Repair of Diabetic Damage by Stromal Cell Administration REDDSTARparticipant5.894.38710
2012-11-01Innovative Midlife Intervention for Dementia deterrence IN-MINDDparticipant2.950.5305
2012-02-01Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer ANGIOPREDICTparticipant5.999.15611
2012-01-01Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high-risk for progression DEXLIFEparticipant5.486.63110
2012-01-01"Self-care Support for People with Long Term Conditions, Diabetes and Heart Disease: A Whole System Approach" EU-WISEparticipant2.935.4349
2011-04-01REsearch into implementation STrategies to support patients of different ORigins and language background in a variety of European primary care settings RESTOREparticipant2.990.5908
2011-04-01Robotics UBIquitous COgnitive Network RUBICONparticipant2.506.76710
2011-02-01CULTivating Understanding and Research through Adaptivity CULTURAparticipant2.869.5257
2011-01-01Glycomics by High-throughput Integrated Technologies GlycoHITparticipant2.993.05615

Alias institution names:

  • PINTAIL